Arcellx (ACLX) Times Interest Earned (2022 - 2025)
Arcellx's quarterly Times Interest Earned came in at -$19787.8 in Q4 2025, down 160.6% year-on-year from $32652.9 in Q4 2024, and down 244.64% quarter-over-quarter from -$5741.5 in Q1 2025.
Arcellx has reported Times Interest Earned for 4 years, with the latest figure at -$19787.8 in Q4 2025.
- For the quarter ending Q4 2025, Times Interest Earned fell 160.6% year-over-year to -$19787.8; the trailing twelve-month figure through Sep 2025 stood at -$12765.9 (down 36678.72% YoY), and the FY2024 full-year result was -$133.56, down 470.93% from the prior year.
- Times Interest Earned for Q4 2025 stood at -$19787.8, down from -$5741.5 in the prior quarter.
- The five-year high for Times Interest Earned was $15.35 in Q4 2023, with the low at -$19787.8 in Q4 2025.
- Average Times Interest Earned over 4 years is -$3628.1, with a median of -$133.26 recorded in 2024.
- Year-over-year, Times Interest Earned surged 142.83% in 2023 and plunged 49559.97% in 2024.
- Tracing ACLX's Times Interest Earned over 4 years: stood at -$35.85 in 2022, then surged by 142.83% to $15.35 in 2023, then sank by 49559.97% to -$7593.1 in 2024, then slumped by 160.6% to -$19787.8 in 2025.
- The last three Times Interest Earned figures came in at -$19787.8 (Q4 2025), -$5741.5 (Q1 2025), and -$7593.1 (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -129.79 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 3.58 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -258.33 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 11.50 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 49.84 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 3.88 |
| 10 | Arcellx | 6.48 Bn | 6.48 Bn | - | -19,787.75 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -19,787.75 |
| Mar 31, 2025 | -5,741.50 |
| Dec 31, 2024 | -7,593.14 |
| Sep 30, 2024 | -294.88 |
| Jun 30, 2024 | -109.01 |
| Mar 31, 2024 | -26.89 |
| Dec 31, 2023 | 15.35 |
| Sep 30, 2023 | -46.78 |
| Jun 30, 2023 | -33.59 |
| Mar 31, 2023 | -29.69 |
| Dec 31, 2022 | -35.85 |
| Sep 30, 2022 | -157.51 |
| Jun 30, 2022 | -10,430.00 |
| Mar 31, 2022 | -6,522.75 |